Tres casos de gammapatía monoclonal de significado renal postrasplante renal: nefropatía c3 de novo

2003, Criteria for the classification of monoclonal gammopathies, multiple mieloma and related disorders: A report of the International Myeloma Working group, Br J Haematol., 121, 749, 10.1046/j.1365-2141.2003.04355.x Bladé, 2008, Pathogenesis and progression of monoclonal gammopathy of undetermined significance, Leukemia., 22, 1651, 10.1038/leu.2008.203 Kyle, 2006, Prevalence of monoclonal gammopathy of undetermined significance, N Engl J Med., 354, 1362, 10.1056/NEJMoa054494 Kyle, 2005, Monoclonal gammopathies of undetermined significance (MGUS), Best Pract Res Clin Haematol., 18, 689, 10.1016/j.beha.2005.01.025 Glavey, 2016, Monoclonal gammopathy: The good, the bad and the ugly, Blood Rev., 30, 223, 10.1016/j.blre.2015.12.001 Sethi, 2016, Spectrum of manifestations of monoclonal gammopathy-associated renal lesions, Curr Opin Neprhol Hypertens., 25, 127, 10.1097/MNH.0000000000000201 Bridoux, 2015, International Kidney and Monoclonal Gammopathy Research Group: Diagnosis of monoclonal gammopathy of renal significance, Kidney Int., 87, 698, 10.1038/ki.2014.408 Caravaca-Fontán, 2017, Gammapatías monoclonales de significado renal, Nefrología., 37, 465, 10.1016/j.nefro.2017.03.012 Lloyd, 2016, C3 glomerulopathy in adults: A distinct patient subset showing frequent association with monoclonal gammopathy and por renal outcome, Clin Kid J., 9, 794, 10.1093/ckj/sfw090 Medjeral-thomas, 2014, C3 glomerulopathy: clinicopathologic features and predictors outcome, Clin J Am Soc Nephrol., 6, 46, 10.2215/CJN.04700513